TECregen raised CHF10M with Boehringer Ingelheim Venture Fund, Zürcher Kantonal Bank, Lifespan Vision Ventures, Carma Fund, JFG Life Sciences, HTGF Biotech Health services Manufacturing Investments 08 December 2025 Share:
Round value (USD): 12.44m Round investors: Boehringer Ingelheim Venture Fund High-Tech Gründerfonds Zürcher Kantonalbank JFG Life Sciences Foundation Carma Fund Lifespan Vision Ventures Company: TECregen Industry: Biotech Health services Manufacturing
Rivia raised $15m in Series A funding led by Earlybird, joined by investors including Defiant, Speedinvest, Amino Collective and Nina Capital. AI (big data) Biotech Competitive Intelligence Health services Software Services Investments 02 March 2026
Berlin Heals raises $10 million more Hardware Health services Manufacturing Investments 03 February 2026
Liom in a CHF 13 million series A extension with Red Bull Ventures and Swiss angel investors Hardware Health services Manufacturing Software Services Investments 03 December 2025
Virometix secured $15 million in a financing round supported by existing shareholders. Biotech Health services Investments 03 November 2025
Indivi in a CHF 15 million equity finance round led by Ava Investors Biotech Hardware Health services Software Services Wearable Investments 17 October 2025